Applications of 1-Amino-3,3-Diethoxypropane in Industrial Manufacturing

1-Amino-3,3-Diethoxypropane serves as a critical intermediate across several specialized fields. Our production follows consistent and traceable protocols to meet the stringent requirements of global industrial and research-based manufacturing.

1. API Intermediate in Aceclofenac Synthesis

In pharmaceutical synthesis, 1-Amino-3,3-Diethoxypropane functions as an aminoacetal building block, especially in the multi-step production of aceclofenac and related arylacetic acid derivatives. Its use allows for controlled chain extension and stabilizes intermediate compounds during alkylation and amide formation steps. The aminoacetal group enables precise modification without unwanted side reactions, supporting batch reproducibility and impurity control as dictated by regulated environments.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia Monograph 01/2023:1185 (Aceclofenac)
• US FDA 21 CFR Part 211 (GMP for Finished Pharmaceuticals)
• ISO 9001:2015 for quality management systems in pharma intermediates

Typical usage ratio

• 0.85–1.1 mol per mol of parent aryl haloacetate, adjusted to minimize byproducts

Downstream process integration

• Introduced after initial halogenation, precedes final hydrolysis in batch or continuous reactors under strictly anhydrous conditions to avoid premature cleavage

Final product types

• Aceclofenac bulk active pharmaceutical ingredient
• Diclofenac analogs
• Other non-steroidal anti-inflammatory agent APIs

2. Advanced Agrochemical Synthesis

Producers utilize this compound in the construction of novel herbicide and insecticide scaffolds, including pyridine and pyrazole derivatives. The dual ethoxy protection provides efficient control during chain elongation and targeted amination steps. Agrochemical formulators find its use beneficial for introducing branched side chains, granting selectivity and metabolic stability. Process adjustments optimize both reaction yield and environmental compliance.

Industry compliance standards

• FAO/WHO Codex Alimentarius for pesticide intermediates
• REACH Regulation (EC) No 1907/2006 for chemical substance registration
• China GB/T 19001-2016/ISO 9001:2015 Quality Management
• OECD Guidelines for the Testing of Chemicals

Typical usage ratio

• 0.75–1.3 equivalents per target ring compound, modified per downstream crop selectivity requirements

Downstream process integration

• Acts after chlorinated ring formation, prior to final coupling with carboxylic acid or phosphoramide moieties, often under controlled temperature and nitrogen atmosphere

Final product types

• Pyridine-based herbicide actives
• N-alkyl pyrazole insecticides
• Pre-emergence weed control formulations
• Intermediate stock for custom blend agrochemicals

3. Polyurethane Modified Resin Manufacturing

Manufacturers of specialty polyurethanes incorporate this chemical to prepare blocked isocyanate-modified resins and latent hardeners. Its amino functionality allows controlled chain extension, while the diethoxy groups offer hydrolytic stability during storage. Upon deprotection, this intermediate enables the fine-tuning of crosslink density and flexibility in 2K coatings and adhesives. Operators can optimize performance for automotive, marine, and electronics applications through careful dosage and process monitoring.

Industry compliance standards

• ISO 9001:2015 for quality systems in polymer production
• EU Regulation (EC) No 1272/2008 on classification, labeling, and packaging (CLP)
• ASTM D16 Standard Terminology for Paint, Related Coatings, Materials
• RoHS Directive 2011/65/EU for restricted substances in electronics adhesives

Typical usage ratio

• 0.2–0.7 mol per mol of polyol backbone, allowing adjustment for target mechanical properties and cure profiles

Downstream process integration

• Added post-initial polymer formation, preceding isocyanate blocking and neutralization steps, often at 50–75°C in closed reactors

Final product types

• 2K polyurethane coatings for automotive refinish
• Flexible polyurethane adhesives and sealants
• Electronic encapsulation compounds
• Waterborne polyurethane dispersions

4. Fine Chemical Intermediates for Fragrance & Aroma Synthesis

In the synthesis of fragrance aldehydes and specialty flavor molecules, this aminoacetal enables the controlled introduction of alkyl chains. The compound’s protected form provides stability during subsequent condensation and hydrolysis steps. Its selective reactivity limits the formation of unwanted isomers, essential for maintaining purity in high-value aroma derivatives. Production sites benefit from predictable yields and simplified downstream isolation of aldehydes or acids.

Industry compliance standards

• IFRA (International Fragrance Association) Standards
• EU Regulation (EC) No. 1223/2009 on cosmetic products
• ISO 9001:2015 for raw material traceability in fragrance manufacturing
• FEMA GRAS Program (for select aroma chemicals)

Typical usage ratio

• 1.0–1.2 equivalents per aldehyde or ester precursor, refined by required fragrance profile and target batch yield

Downstream process integration

• Introduced after initial acylation step; deprotection and final purification carried out at ambient or reduced pressure to capture volatile fractions

Final product types

• Linear and branched fragrance aldehydes
• Specialty aroma acids for fine fragrance
• Flavor and aroma intermediates for beverage blends
• Perfumery bases for cosmetic and toiletry applications

5. Construction of Heterocyclic Pharmaceutical Building Blocks

Process chemists rely on this reagent for the stepwise synthesis of 5- and 6-membered nitrogen heterocycles, forming scaffolds for CNS-active drugs and antihypertensives. Its protected amino group ensures selective 1,3-difunctionalization, which increases yield of target heterocycles and controls side-product formation. Multi-stage production environments benefit from its compatibility with a range of condensation and cyclization chemistries performed under anhydrous or controlled pH conditions.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• Japanese Pharmacopoeia for registered intermediate approval
• US FDA ICH Q3A(R2) for impurity management in new APIs
• GMP audit trails for heterocyclic intermediate production

Typical usage ratio

• 0.9–1.2 equivalents per nucleophile or alkylation substrate, titrated by analytical HPLC during scale-up

Downstream process integration

• Added in the cyclization precursor step, followed by in situ deprotection and ring closure under inert or nitrogen conditions

Final product types

• Pyrrolidine core intermediates
• Piperidine analogs for antihypertensives
• CNS drug scaffolds
• Custom heterocyclic building blocks